Stockreport

Minerva Neurosciences: Plodding Ahead After Another Roluperidone Delay In Negative Symptoms Of Schizophrenia [Seeking Alpha]

Minerva Neurosciences, Inc  (NERV) 
Last minerva neurosciences, inc earnings: 3/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.minervaneurosciences.com/investor-relations
PDF NERV stock has declined approximately 34% from ~$9.75, reflecting a turbulent period with dramatic price swings. My prior assessment remains relevant as NERV continue [Read more]